Get the Stockscreener App
5.9843
1.87%
0.1143
Goodrx Holdings Inc stock is traded at $5.9843, with a volume of 418.73K.
It is up +1.87% in the last 24 hours and down -15.66% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$5.87
Open:
$5.87
24h Volume:
418.73K
Relative Volume:
0.34
Market Cap:
$2.27B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
237.47
EPS:
0.0252
Net Cash Flow:
$64.06M
1W Performance:
-6.71%
1M Performance:
-15.66%
6M Performance:
-15.77%
1Y Performance:
+11.36%
1-Day Range:
$5.82
$6.0297
1-Week Range:
$5.82
$6.52
52-Week Range:
$4.135
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Raymond James & Associates Boosts Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Vanguard Group Inc's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies - Reuters
GoodRx to Participate in Upcoming Investor Conferences - StockTitan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
How To Trade (GDRX) - Stock Traders Daily
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm - ForexTV.com
GoodRx Unveils New E-commerce Platform, Launches with Opill® - Quantisnow
Assenagon Asset Management S.A. Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx (GDRX) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
GoodRx (GDRX) Set to Announce Earnings on Thursday - Defense World
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon - Simply Wall St
GoodRx appoints IQVIA CFO to board for financial expertise - Investing.com India
GoodRx Holdings Strengthens Board with New Appointment - TipRanks
Ronald E. Bruehlman Joins GoodRx Board of Directors - StockTitan
GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade) (NASDAQ:GDRX) - Seeking Alpha
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus.com
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies - Marketscreener.com
Vontobel Holding Ltd. Purchases 41,196 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
(GDRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Google, Meta Want Out Of GoodRx Health Data Sharing Suit - Law360
GoodRx Holdings Inc’s latest rating changes from various analysts - Knox Daily
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers - StockTitan
Cubist Systematic Strategies LLC Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Head-To-Head Comparison: GoodRx (NASDAQ:GDRX) versus CarGurus (NASDAQ:CARG) - Defense World
GoodRx Holdings Inc (GDRX) expanding its growth trajectory ahead - SETE News
Trading (GDRX) With Integrated Risk Controls - Stock Traders Daily
BANK OF NOVA SCOTIA's Strategic Acquisition of GoodRx Holdings I - GuruFocus.com
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Business Wire
ELV vs. GDRX: Which Stock Is the Better Value Option? - MSN
GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges - Yahoo Finance
GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Rev - GuruFocus.com
What is the investor’s view on GoodRx Holdings Inc (GDRX)? - US Post News
GoodRx Holdings Inc [GDRX] Spectrum Equity VII, L.P. sells 10,677 Shares for $83922.0 - Knox Daily
Marshall Wace LLP Makes New Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx Holdings: Failing To Gain Much Traction - Seeking Alpha
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Cubist Systematic Strategies LLC - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Dimensional Fund Advisors LP Decreases Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Algert Global LLC Raises Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Financial Snapshot: Analyzing GoodRx Holdings Inc (GDRX)’s Key Ratio Metrics - The Dwinnex
Do investors need to be concerned about GoodRx Holdings Inc (GDRX)? - US Post News
GoodRx Holdings, Inc. to Post FY2025 Earnings of $0.23 Per Share, Leerink Partnrs Forecasts (NASDAQ:GDRX) - MarketBeat
Millennium Management LLC Increases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
Analyzing GoodRx Holdings Inc (GDRX) After Recent Trading Activity - Knox Daily
High Growth Tech Stocks In The United States To Watch - Simply Wall St
FY2024 EPS Estimates for GoodRx Holdings, Inc. Lowered by Analyst (NASDAQ:GDRX) - Defense World
FY2024 EPS Estimates for GoodRx Holdings, Inc. Decreased by Leerink Partnrs (NASDAQ:GDRX) - MarketBeat
GoodRx stock maintains Outperform rating from Leerink Partners By Investing.com - Investing.com Canada
GoodRx stock maintains Outperform rating from Leerink Partners - Investing.com
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):